Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,191.42 +11.74 (+0.14%) Bitcoin USD
61,058.93 -1,162.37 (-1.87%) CMC Crypto 200
1,278.03 -5.80 (-0.45%)
Cidara Therapeutics, Inc. (20D0.F)
Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
As of 08:11AM CEST. Market open.
Currency in
Valuation measures4
| Market cap (intra-day) | 47.80M |
| Enterprise value | 24.98M |
| Trailing P/E | N/A |
| Forward P/E | 5.63 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.00 |
| Price/book (mrq) | 7.31 |
| Enterprise value/revenue | 0.58 |
| Enterprise value/EBITDA | -1.88 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | -52.06% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 23.0000 |
| 52-week low 3 | 9.5600 |
| 50-day moving average 3 | 9.6582 |
| 200-day moving average 3 | 12.8816 |
Share statistics
| Avg vol (3-month) 3 | 29 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 4.56M |
| Implied shares outstanding 6 | 5M |
| Float 8 | 3.88M |
| % held by insiders 1 | 7.34% |
| % held by institutions 1 | 29.55% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 24 Apr 2024 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -78.40% |
| Operating margin (ttm) | -126.33% |
Management effectiveness
| Return on assets (ttm) | -35.29% |
| Return on equity (ttm) | -800.93% |
Income statement
| Revenue (ttm) | 46.26M |
| Revenue per share (ttm) | 10.23 |
| Quarterly revenue growth (yoy) | -67.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -37.84M |
| Net income avi to common (ttm) | -35.63M |
| Diluted EPS (ttm) | -7.5700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 29.02M |
| Total cash per share (mrq) | 6.36 |
| Total debt (mrq) | 4.65M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.72 |
| Book value per share (mrq) | -3.90 |
Cash flow statement
| Operating cash flow (ttm) | -18.18M |
| Levered free cash flow (ttm) | 21.82M |
© 2024 Yahoo. All rights reserved.